These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16451069)

  • 1. SAR and mode of action of novel non-nucleoside inhibitors of hepatitis C NS5b RNA polymerase.
    Powers JP; Piper DE; Li Y; Mayorga V; Anzola J; Chen JM; Jaen JC; Lee G; Liu J; Peterson MG; Tonn GR; Ye Q; Walker NP; Wang Z
    J Med Chem; 2006 Feb; 49(3):1034-46. PubMed ID: 16451069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-based design of a novel thiazolone scaffold as HCV NS5B polymerase allosteric inhibitors.
    Yan S; Appleby T; Larson G; Wu JZ; Hamatake R; Hong Z; Yao N
    Bioorg Med Chem Lett; 2006 Nov; 16(22):5888-91. PubMed ID: 16934455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and structure-based optimization of novel dihydropyrones as potent HCV RNA polymerase inhibitors.
    Li H; Tatlock J; Linton A; Gonzalez J; Borchardt A; Dragovich P; Jewell T; Prins T; Zhou R; Blazel J; Parge H; Love R; Hickey M; Doan C; Shi S; Duggal R; Lewis C; Fuhrman S
    Bioorg Med Chem Lett; 2006 Sep; 16(18):4834-8. PubMed ID: 16824756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel thiazolones as HCV NS5B polymerase allosteric inhibitors: Further designs, SAR, and X-ray complex structure.
    Yan S; Larson G; Wu JZ; Appleby T; Ding Y; Hamatake R; Hong Z; Yao N
    Bioorg Med Chem Lett; 2007 Jan; 17(1):63-7. PubMed ID: 17049849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of pyrano[3,4-b]indoles as potent and selective HCV NS5B polymerase inhibitors.
    Gopalsamy A; Lim K; Ciszewski G; Park K; Ellingboe JW; Bloom J; Insaf S; Upeslacis J; Mansour TS; Krishnamurthy G; Damarla M; Pyatski Y; Ho D; Howe AY; Orlowski M; Feld B; O'Connell J
    J Med Chem; 2004 Dec; 47(26):6603-8. PubMed ID: 15588095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of potent and broad genotypically active NS5B HCV non-nucleoside inhibitors binding to the thumb domain allosteric site 2 of the viral polymerase.
    Pierra Rouvière C; Amador A; Badaroux E; Convard T; Da Costa D; Dukhan D; Griffe L; Griffon JF; LaColla M; Leroy F; Liuzzi M; Loi AG; McCarville J; Mascia V; Milhau J; Onidi L; Paparin JL; Rahali R; Sais E; Seifer M; Surleraux D; Standring D; Dousson C
    Bioorg Med Chem Lett; 2016 Sep; 26(18):4536-4541. PubMed ID: 27520942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis for resistance of the genotype 2b hepatitis C virus NS5B polymerase to site A non-nucleoside inhibitors.
    Rydberg EH; Cellucci A; Bartholomew L; Mattu M; Barbato G; Ludmerer SW; Graham DJ; Altamura S; Paonessa G; De Francesco R; Migliaccio G; Carfí A
    J Mol Biol; 2009 Jul; 390(5):1048-59. PubMed ID: 19505479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of substituted N-phenylbenzenesulphonamides as a novel class of non-nucleoside hepatitis C virus polymerase inhibitors.
    May MM; Brohm D; Harrenga A; Marquardt T; Riedl B; Kreuter J; Zimmermann H; Ruebsamen-Schaeff H; Urban A
    Antiviral Res; 2012 Aug; 95(2):182-91. PubMed ID: 22580131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of proline sulfonamides as potent and selective hepatitis C virus NS5b polymerase inhibitors. Evidence for a new NS5b polymerase binding site.
    Gopalsamy A; Chopra R; Lim K; Ciszewski G; Shi M; Curran KJ; Sukits SF; Svenson K; Bard J; Ellingboe JW; Agarwal A; Krishnamurthy G; Howe AY; Orlowski M; Feld B; O'Connell J; Mansour TS
    J Med Chem; 2006 Jun; 49(11):3052-5. PubMed ID: 16722622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of anthranilic acid derivatives as a novel class of allosteric inhibitors of hepatitis C NS5B polymerase.
    Nittoli T; Curran K; Insaf S; DiGrandi M; Orlowski M; Chopra R; Agarwal A; Howe AY; Prashad A; Floyd MB; Johnson B; Sutherland A; Wheless K; Feld B; O'Connell J; Mansour TS; Bloom J
    J Med Chem; 2007 May; 50(9):2108-16. PubMed ID: 17402724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-nucleoside inhibitors of HCV NS5B polymerase. Part 1: Synthetic and computational exploration of the binding modes of benzothiadiazine and 1,4-benzothiazine HCV NS5b polymerase inhibitors.
    Hendricks RT; Fell JB; Blake JF; Fischer JP; Robinson JE; Spencer SR; Stengel PJ; Bernacki AL; Leveque VJ; Le Pogam S; Rajyaguru S; Najera I; Josey JA; Harris JR; Swallow S
    Bioorg Med Chem Lett; 2009 Jul; 19(13):3637-41. PubMed ID: 19447623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and biological evaluation of a series of 1H-benzo[de]isoquinoline-1,3(2H)-diones as hepatitis C virus NS5B polymerase inhibitors.
    Ontoria JM; Rydberg EH; Di Marco S; Tomei L; Attenni B; Malancona S; Martin Hernando JI; Gennari N; Koch U; Narjes F; Rowley M; Summa V; Carroll SS; Olsen DB; De Francesco R; Altamura S; Migliaccio G; Carfì A
    J Med Chem; 2009 Aug; 52(16):5217-27. PubMed ID: 19877603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fragment-based discovery of hepatitis C virus NS5b RNA polymerase inhibitors.
    Antonysamy SS; Aubol B; Blaney J; Browner MF; Giannetti AM; Harris SF; Hébert N; Hendle J; Hopkins S; Jefferson E; Kissinger C; Leveque V; Marciano D; McGee E; Nájera I; Nolan B; Tomimoto M; Torres E; Wright T
    Bioorg Med Chem Lett; 2008 May; 18(9):2990-5. PubMed ID: 18400495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-based virtual screening, synthesis and SAR of novel inhibitors of hepatitis C virus NS5B polymerase.
    Talele TT; Arora P; Kulkarni SS; Patel MR; Singh S; Chudayeu M; Kaushik-Basu N
    Bioorg Med Chem; 2010 Jul; 18(13):4630-8. PubMed ID: 20627595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-nucleoside inhibitors binding to hepatitis C virus NS5B polymerase reveal a novel mechanism of inhibition.
    Biswal BK; Wang M; Cherney MM; Chan L; Yannopoulos CG; Bilimoria D; Bedard J; James MN
    J Mol Biol; 2006 Aug; 361(1):33-45. PubMed ID: 16828488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-nucleoside inhibitors of HCV polymerase NS5B. Part 4: structure-based design, synthesis, and biological evaluation of benzo[d]isothiazole-1,1-dioxides.
    de Vicente J; Hendricks RT; Smith DB; Fell JB; Fischer J; Spencer SR; Stengel PJ; Mohr P; Robinson JE; Blake JF; Hilgenkamp RK; Yee C; Adjabeng G; Elworthy TR; Li J; Wang B; Bamberg JT; Harris SF; Wong A; Leveque VJ; Najera I; Le Pogam S; Rajyaguru S; Ao-Ieong G; Alexandrova L; Larrabee S; Brandl M; Briggs A; Sukhtankar S; Farrell R
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5652-6. PubMed ID: 19709881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding site characterization and resistance to a class of non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase.
    Kukolj G; McGibbon GA; McKercher G; Marquis M; Lefèbvre S; Thauvette L; Gauthier J; Goulet S; Poupart MA; Beaulieu PL
    J Biol Chem; 2005 Nov; 280(47):39260-7. PubMed ID: 16188890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and initial optimization of alkoxyanthranilic acid derivatives as inhibitors of HCV NS5B polymerase.
    Parcella K; Nickel A; Beno BR; Sheriff S; Wan C; Wang YK; Roberts SB; Meanwell NA; Kadow JF
    Bioorg Med Chem Lett; 2017 Jan; 27(2):295-298. PubMed ID: 27908764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structures of the RNA-dependent RNA polymerase genotype 2a of hepatitis C virus reveal two conformations and suggest mechanisms of inhibition by non-nucleoside inhibitors.
    Biswal BK; Cherney MM; Wang M; Chan L; Yannopoulos CG; Bilimoria D; Nicolas O; Bedard J; James MN
    J Biol Chem; 2005 May; 280(18):18202-10. PubMed ID: 15746101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isothiazoles as active-site inhibitors of HCV NS5B polymerase.
    Yan S; Appleby T; Gunic E; Shim JH; Tasu T; Kim H; Rong F; Chen H; Hamatake R; Wu JZ; Hong Z; Yao N
    Bioorg Med Chem Lett; 2007 Jan; 17(1):28-33. PubMed ID: 17049853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.